Thursday, April 18, 2013 1:40:47 PM
Not at all, it may be great stuff and someday save lives, but it won't happen using Bergamo's money, because that have none. The big question here is why would someone with something so good a take a chance on getting in business with a company like Bergamo. If had they done a minimum amount of due diligence, they could plainly see that BGMO has promised much in the past, but never on anything. Plus, they never once publicly explained why every single deal was not consummated. They just go on the next scam like the last one never happened. The SEC won't touch them because they're a non-reporting pinkie. Vista, on the hand, has to be very careful about what they report. They probably look at this as a 20-80 proposition, but what they risk is the public will think they're not very smart, just very, very, desperate for cash. IMO, Chapter 11 is next, then maybe some fresh capital shows up to finish the technology. Like I said, JMO.
Recent VTGN News
- Kuehn Law Encourages Investors of Vistagen Therapeutics, Inc. to Contact Law Firm • PR Newswire (US) • 06/01/2026 06:40:00 PM
- Vistagen to Participate in Jefferies 2026 Global Healthcare Conference • Business Wire • 05/27/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:52:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:51:49 PM
- Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer • Business Wire • 05/19/2026 12:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:26:37 PM
- Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference • Business Wire • 05/14/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:44:41 AM
- Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder • Business Wire • 05/12/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:30:08 PM
- Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder • Business Wire • 05/08/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:13:15 PM
- Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Investor Alert: Schubert Jonckheer Investigating Possible False Claims Regarding Drug Candidate Following 80% Stock Drop • PR Newswire (US) • 04/28/2026 01:00:00 PM
- Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause • Business Wire • 04/22/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 09:27:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:43:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:41:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:33:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 08:45:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:38 PM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/16/2026 06:38:00 AM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/12/2026 07:29:00 AM
